The need for patient and clinician safety is receiving the highest of priority in the preparation and administration of hazardous/non-hazardous drugs. In the U.S. in 2012, an estimated 14,000 patients in 23 U.S. states received injections of contaminated drugs in a meningitis outbreak. That outbreak sickened 778 patients nationwide, including 76 who died, after receiving contaminated steroids.
In 2013 there were a total of 1,176 cancer patients in Ontario and New Brunswick that received chemotherapy cocktails that were watered down. The cause was human error but the impact was enormous. Safety has now become a prime focus in all areas of pharmacy preparation and administration of drugs. With agencies like Ontario Cancer Care highlighting the importance of Safety First in their Business Plan, similar agencies in other provinces are showing similar intent and mandates in the proper care of cytotoxic drugs.
“Innovative OncoSolutions strives to improve accessibility of cancer drugs to patients in need. Our solutions enhance the safety and health of patients and healthcare providers.”
-Cathy Bratt- Rico, President